A rating of 84 puts Soleno Therapeutics Inc (SLNO) near the top of the Biotechnology industry according to InvestorsObserver. Soleno Therapeutics Inc's score of 84 means it scores higher than 84% of stocks in the industry. Soleno Therapeutics Inc also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 20 out of the 148 industries.
SLNO has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on SLNO!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Soleno Therapeutics Inc Stock Today?
Soleno Therapeutics Inc (SLNO) stock is trading at $47.07 as of 3:22 PM on Wednesday, Feb 14, an increase of $1.22, or 2.67% from the previous closing price of $45.84. The stock has traded between $46.01 and $47.47 so far today. Volume today is low. So far 189,718 shares have traded compared to average volume of 255,938 shares.
Click Here to get the full Stock Report for Soleno Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
